SciClone Pharmaceuticals (Holdings) (HKSE:06600) Change In Inventory : HK$0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SciClone Pharmaceuticals (Holdings) Change In Inventory?

SciClone Pharmaceuticals (Holdings)'s change in inventory for the quarter that ended in Dec. 2023 was HK$0 Mil. It means SciClone Pharmaceuticals (Holdings)'s inventory stayed the same from Jun. 2023 to Dec. 2023 .

SciClone Pharmaceuticals (Holdings)'s change in inventory for the fiscal year that ended in Dec. 2023 was HK$-191 Mil. It means SciClone Pharmaceuticals (Holdings)'s inventory increased by HK$191 Mil from Dec. 2022 to Dec. 2023 .

SciClone Pharmaceuticals (Holdings)'s Total Inventories for the quarter that ended in Dec. 2023 was HK$337 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. SciClone Pharmaceuticals (Holdings)'s Days Inventory for the quarter that ended in Dec. 2023 was 98.96.

Inventory Turnover measures how fast the company turns over its inventory within a year. SciClone Pharmaceuticals (Holdings)'s Inventory Turnover for the quarter that ended in Dec. 2023 was 1.84.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. SciClone Pharmaceuticals (Holdings)'s Inventory-to-Revenue for the quarter that ended in Dec. 2023 was 0.14.

SciClone Pharmaceuticals (Holdings) Change In Inventory Historical Data

The historical data trend for SciClone Pharmaceuticals (Holdings)'s Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciClone Pharmaceuticals (Holdings) Change In Inventory Chart

SciClone Pharmaceuticals (Holdings) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Get a 7-Day Free Trial

8.35

-48.67

-16.03

30.88

-190.73

SciClone Pharmaceuticals (Holdings) Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Inventory	Get a 7-Day Free Trial						-	-	-	-	-

SciClone Pharmaceuticals (Holdings) Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

SciClone Pharmaceuticals (Holdings)'s Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	231.774	/	427.446	*	365 / 2
	=	98.96

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

SciClone Pharmaceuticals (Holdings)'s Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	427.446	/	231.774
	=	1.84

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

SciClone Pharmaceuticals (Holdings)'s Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	231.774	/	1697.854
	=	0.14

SciClone Pharmaceuticals (Holdings) Change In Inventory Related Terms

Thank you for viewing the detailed overview of SciClone Pharmaceuticals (Holdings)'s Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SciClone Pharmaceuticals (Holdings) Ltd (HKSE:06600) » Definitions » Change In Inventory

Traded in Other Exchanges

N/A

Address

381 Middle Huaihai Road, 22nd Floor, Central Plaza, Shanghai, CHN

Website

https://www.sciclone.com

SciClone Pharmaceuticals (Holdings) Ltd is a biopharmaceutical company with an integrated platform for product development and commercialization. It strategically focuses on some of the fast-growing therapeutic areas with unmet medical needs in China, primarily including oncology and severe infection. It generated revenue primarily from the sale of Zadaxin to Sinopharm.

Executives

Ubs Group Ag	2201 Interest of corporation controlled by you
Zhao Hong	2101 Beneficial owner
Gl Capital Management Gp Limited
Meng Liang	2201 Interest of corporation controlled by you
Ascendent Silver (cayman) Limited	2501 Other
Ascendent Capital Partners Ii Gp Limited	2201 Interest of corporation controlled by you
Ascendent Capital Partners Ii, Gp, L.p.	2201 Interest of corporation controlled by you
Ascendent Capital Partners Ii, L.p.	2201 Interest of corporation controlled by you
Gl Partners Capital Management Ltd.
Gl China Opportunities Carry Gp Limited
Ocean Falcon Limited	2101 Beneficial owner
Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Bank Of China Limited	2201 Interest of corporation controlled by you
Bank Of China Group Investment Limited	2201 Interest of corporation controlled by you
Gl Capital Management Gp Ii B.c I. Ltd

SciClone Pharmaceuticals (Holdings) (HKSE:06600) Headlines

No Headlines